Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000310 · ClinicalTrials.gov registry record · Phase 2
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00000310: Clinical Trial Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000310 is a Phase 2 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000310, a Phase 2 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
Interventions
- DRUG Risperidone
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-01 |
| Est. Completion | 1996-03 |
| Phase | Phase 2 |
Why NCT00000310 stopped before completion
NCT00000310 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Risperidone is the first listed.
NCT00000310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000310 about?
NCT00000310 is a clinical study titled "Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2". The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
What is the current status of trial NCT00000310?
This trial is currently terminated. It is a Phase 2 study. The study started on 1996-01. Estimated completion is 1996-03.
What interventions are being tested in trial NCT00000310?
The interventions under investigation include: Risperidone (DRUG).
Who is sponsoring clinical trial NCT00000310?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia